In the NAFLD mice, we found that treatment with Sr significantly increased the density of c-Fos+ cells in the hippocampus and inhibited the expression of caspase-3 by suppressing ERS. The gene discussed is FOS; the disease is metabolic dysfunction-associated steatotic liver disease.